about Semaglutide

Semaglutide is a member of a class of drugs that have been used for diabetes management for over a decade – GLP1-RAs (glucagon-like peptide 1 receptor agonists). The weight loss effects of these agents has been known for some time, however, semaglutide appears to be the “best-in-class” GLP-1 RA for weight loss and was recently approved for weight loss by the FDA under the brand name Wegovy^®

Semaglutide has proven to be a very effective weight loss modality. Coupled with diet and lifestyle modification, our patients have experienced a 4-10lb. weight loss/month.

Currently, we are only offering semaglutide as a once-weekly subcutaneous injection.

how does Semaglutide work?

Semaglutide mimics the effect of “feeling full” resulting in a decreased caloric intake. Semaglutide will delay gastric emptying by reducing glucagon secretion in a glucose-dependent manner. The delay in gastric emptying can reduce appetite, improve control of eating, and reduce food cravings.

You will need a medical evaluation prior to beginning therapy and every three months to make certain you are a candidate for this program.